What If There Had Been No COVID Coup? Authored by Debbie Lerman via The Brownstone Institute, In discussions about the military and national...
Last Monday, Jason Gardner became the latest biotech veteran to join the sprawling biotech incubator Flagship Pioneering as a CEO-partner and as chief...
The Unforgivable Ivermectin Swindle Submitted by QTR's Fringe Finance This month, lawyers for the Food and Drug Administration admitted in...
FDA Approved 65% Of New Drugs In 2022 Based On A Single Study Authored by Megan Redshaw JD via The Epoch Times (emphasis ours), The 21st...
When it comes to translational medicine, Robert Gourdie is among the 2 percent of “super-producers,” National Institutes of Health-funded scientists...
Cocrystal Pharma, a Seattle-area company co-founded by a Nobel Prize winner and backed by biotech veterans, is taking aim at high-profile viruses. The...
Cocrystal Pharma, a Seattle-area company co-founded by a Nobel Prize winner and backed by biotech veterans, is taking aim at high-profile viruses. The...
Welcome to TDR’s review of the Top 5 Psychedelic Developments for the week of August 7. Aside from presenting a synopsis of events, we provide market...
Three therapeutic regulatory approvals in less than a year signal that the promise of the human microbiome may finally be paying off. All of the approved...
Medical exploitation is an often overlooked part of Black history and partly explains the mistrust that members of the Black community have for the medical...
"Your Injections Are Killing Our Young People" - Pfizer, Moderna Reps Slammed During Heated Aussie Senate Hearing Authored by Debra Heine...
Decentralized clinical trials startup Curebase has laid off many employees as the company scraps its clinical operations business to focus on software,...
Lawrence A. Tabak, D.D.S., Ph.D., acting director for the National Institutes of Health (NIH), has named Jeanne M. Marrazzo, M.D., as director of NIH’s...
Raymond N. DuBois, M.D., Ph.D., director of MUSC Hollings Cancer Center, has been inducted as a fellow into the Royal College of Physicians (RCP). Credit:...
Monday, July 31, 2023 Credit: Pfizer EMBARGOED FOR RELEASE Monday, July 31, 2023 Noon EDT Contact NIH Office of Communications and Public Liaison NIH News...
COVID Vaccines Show 24 Times More Adverse Reactions Than Others Authored by Jessie Zhang via The Epoch Times (emphasis ours), An Australian...
New York, NY (July 27, 2023)—Investigators at the Icahn School of Medicine at Mount Sinai have designed an innovative RNA-based strategy to activate...
'Serious Doubt' About COVID-19 Vaccine Safety After Forced Release Of 15,000 Pages Of Clinical Trial Data Authored by Tom Ozimek via The Epoch...
CDC Changed Definition Of Breakthrough COVID-19 After Emails About 'Vaccine Failure' Authored by Zachary Stieber via The Epoch Times, The...
It’s easy to forget that change takes time. Drugmakers and industry organizations have launched a wave of diversity, equity and inclusion efforts over...
Trans-Tasman research collaborators from Te Herenga Waka— Victoria University of Wellington’s Ferrier Research Institute and the Malaghan Institute...
Odysseus eventually made it to shore, as BridgeBio CEO Neil Kumar reminded the industry last Friday in a nod to Homer’s classic tale. And on Monday,...
The House of Representatives passed its wide-reaching defense spending bill Friday on a largely party-line vote, greenlighting a bipartisan provision that...
We’re inside the headquarters of Outpace Bio in Seattle. Senior scientist Bobby Langan shows a video of one of his favorite deep-learning tools, used...
CDC Director Concerned About 'Breakthrough' Cases Weeks After COVID Vaccine Rollout: Email Authored by Zachary Stieber via The Epoch Times...
WASHINGTON, D.C. [June 15, 2023] — Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—convened a policy...
Most people are familiar with RNA in the form of the mRNA vaccine against COVID-19. But in a medical sense, RNA can be used for much...
Investigators have announced the completion of participant enrolments into the PrEPVacc trial at all four sites in East and Southern Africa. Led by African...
Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine (“Insilico”), a generative artificial intelligence (AI)-driven drug discovery company,...
California and Taipei biotech Acepodia has lined up another six-figure funding round to take its off-the-shelf cell therapies forward. Spun out of Nobel...